The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.

Content Provider	Europe PMC
Author	Aryanian, Zeinab Balighi, Kamran Hatami, Parvaneh Afshar, Zeinab Mohseni Mohandesi, Nessa Aghazadeh
Abstract	AbstractThe prevalence of hair loss has increased during COVID‐19. In this study, we review the current literature on incidence and characteristics of various types of COVID‐19‐related and COVID‐19‐vaccine‐ related hair loss including telogen effluvium, alopecia areata, friction alopecia and anagen effluvium. Regarding most of them, the more severe the infection, the more profound and prolonged the course of alopecia. However, the most important issue is reassuring the patients of the non‐serious nature of this complication, since psychological support is the most important factor in the earlier resolution of the condition.
Related Links	https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC9111640&blobtype=pdf
Page Count	5
ISSN	13960296
Journal	Dermatologic Therapy [Dermatol Ther]
Volume Number	35
DOI	10.1111/dth.15433
PubMed Central reference number	PMC9111640
Issue Number	6
PubMed reference number	35266262
e-ISSN	15298019
Language	English
Publisher	John Wiley & Sons, Inc.
Publisher Date	2022-04-01
Publisher Place	Hoboken, USA
Access Restriction	Open
Rights License	This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. © 2022 Wiley Periodicals LLC.
Subject Keyword	alopecia areata anagen effluvium COVID vaccine COVID‐19 friction alopecia telogen effluvium
Content Type	Text
Resource Type	Article
Subject	Dermatology